Furthermore, many women do not know actions to cut breast cancer risk.

An experimental analysis sought to determine the usefulness of a natural language processing approach to measure openness of communication about genetic risk within families with hereditary breast and ovarian cancer syndrome.

Relative risk for delay about twofold higher for Black, non-Black patients in highest- versus lowest-risk region.

Immune-related gene expression signatures proved more prognostic than tumor-infiltrating lymphocytes for patients with HER2+ breast cancer.

A follow-up study assessed long-term effects of endocrine therapy in breast cancer survivors who reported endocrine therapy-related effects in a previous study.

From 1988 to 2017, there were no significant improvements in breast cancer-specific survival among men in the United States.

A pilot study investigated the effects of a nurse-led education intervention for patients receiving antiestrogen therapy for high risk of breast cancer or to prevent disease recurrence.

WTC model allows for personalized drug testing within 10 days, even for small-sized tumors.

Researchers sought to assess risk of contralateral breast cancer in patients with BRCA1/2 variants and develop a risk prediction model for this population.

Tamoxifen with annual screening reduced invasive breast cancers and breast cancer deaths by 40 and 57 percent, respectively.